 |
|
New cardiovascular risk prediction models developed for women
February 14, 2007Researchers have developed a more accurate way to predict the risk of developing cardiovascular disease among women, according to a study in the February 14 issue of JAMA.
"In the decade between 1956 and 1966, investigators in Framingham, Mass., defined age, hypertension (high blood pressure), smoking, diabetes and hyperlipidemia (high cholesterol levels) as major determinants of coronary heart disease and coined the term coronary risk factors," according to background information provided by the authors. "Over time, these markers were codified into global risk scores for assessment of cardiovascular risk. However, for women, up to 20 percent of all coronary events occur in the absence of these major risk factors, whereas many women with traditional risk factors do not experience coronary events." The authors note that although understanding of cardiovascular disease has changed dramatically in the past half-century, the algorithms (predictive models) for women are largely unchanged from those recommended 40 years ago.
Paul M Ridker, M.D., M.P.H., from Brigham and Women's Hospital, Boston, and colleagues, developed and validated cardiovascular risk algorithms for women based on a large set of traditional and new risk factors. The researchers assessed 35 risk factors among 24,558 initially healthy women (free of cardiovascular disease and cancer at the beginning of the study) 45 years or older from the Women's Health Study who were followed up for a median of 10.2 years for incident (new) cardiovascular events, such as myocardial infarction (heart attack), ischemic stroke, coronary revascularization, and cardiovascular deaths. The researchers used data among a randomly selected two-thirds of the women (n = 16,400) to develop new algorithms that were then tested to compare observed and predicted outcomes in the remaining one-third of women (n = 8,158). The new algorithms are called the Reynolds Risk Score and the clinically simplified model for non-diabetic women includes age, systolic blood pressure, current smoking, total and HDL cholesterol, high sensitivity C-reactive protein (CRP) and parental history of myocardial infarction before age 60.
"In these analyses, large proportions of women with 10-year risk estimates of 5 percent to less than 10 percent or of 10 percent to less than 20 percent based on current ATP-III (Adult Treatment Panel III) risk scores were reclassified at either higher or lower risk of total cardiovascular disease when either of the new algorithms was used," the researchers found.
"We developed, validated and demonstrated highly improved accuracy of two clinical algorithms for global cardiovascular risk prediction that reclassified 40 percent to 50 percent of women at intermediate risk into higher- or lower-risk categories," the authors write. "As 8 to 10 million U.S. women have an ATP-III estimated 10-year risk between 5 percent and 20 percent, application of these data could have an immediate effect on cardiovascular prevention," the authors conclude. "A user-friendly calculator for the Reynolds Risk Score can be freely accessed at http://www.reynoldsriskscore.org."
JAMA and Archives Journals
"In these analyses, large proportions of women with 10-year risk estimates of 5 percent to less than 10 percent or of 10 percent to less than 20 percent based on current ATP-III (Adult Treatment Panel III) risk scores were reclassified at either higher or lower risk of total cardiovascular disease when either of the new algorithms was used," the researchers found.
"We developed, validated and demonstrated highly improved accuracy of two clinical algorithms for global cardiovascular risk prediction that reclassified 40 percent to 50 percent of women at intermediate risk into higher- or lower-risk categories," the authors write. "As 8 to 10 million U.S. women have an ATP-III estimated 10-year risk between 5 percent and 20 percent, application of these data could have an immediate effect on cardiovascular prevention," the authors conclude. "A user-friendly calculator for the Reynolds Risk Score can be freely accessed at http://www.reynoldsriskscore.org."
JAMA and Archives Journals
Cardiovascular Risk Current Events and Cardiovascular Risk News RSSVioxx trial data shows early cardiovascular risk
Evidence of cardiovascular risks associated with taking Vioxx, the popular, nonsteroidal anti-inflammatory drug (rofecoxib), could have been identified nearly four years before its manufacturer, Merck & Co. Inc., voluntarily pulled the drug from the market.
Menopause-cardiology consensus statement on cardiovascular disease and on HRT
A menopause-cardiology consensus statement has called for direct action to prevent cardiovascular disease (CVD) in menopausal women. The statement also concludes that there is little evidence of increased CVD risk in taking HRT.
Diabetes surgery summit consensus lays foundation for new field of medicine
A first-of-its-kind consensus statement on diabetes surgery is published online today in the Annals of Surgery.
Genetic analysis helps dissect molecular basis of cardiovascular disease
Using highly precise measurements of plasma lipoprotein concentrations determined by nuclear magnetic resonance spectroscopy (NMR), researchers led by Daniel Chasman at Brigham and Women's Hospital and Harvard Medical School in Boston, MA, the Framingham Heart Study in Framingham, and the PROCARDIS consortium in Stockholm, Sweden and Oxford, England performed genetic association analysis across the whole genome among 17,296 women of European ancestry from the Women's Genome Health Study.
Night Beat, Overtime and a Disrupted Sleep Pattern Can Harm Officers' Health
A police officer who works the night shift, typically from 8 p.m. to 4 a.m., already is at a disadvantage when it comes to getting a good "night's" sleep.
A decade later, lifestyle changes or metformin still lower type 2 diabetes risk
Intensive lifestyle changes aimed at modest weight loss reduced the rate of developing type 2 diabetes by 34 percent compared with placebo in people at high risk for the disease, researchers conclude based on 10 years of data.
Research: Migraine and cardiovascular disease: Systematic review and meta-analysis
Migraine with aura (temporary visual or sensory disturbances before or during a migraine headache) is associated with a twofold increased risk of stroke, finds a study published on bmj.com today.
Web-based nutrition program reduces health care costs for employees with cardiac risk factors
Researchers from Boston University School of Medicine (BUSM) and Boston University School of Public Health (BUSPH) have shown that an employer-sponsored, internet-based diet and exercise program shows promise as a low-cost benefit to lower healthcare costs for those at higher risk for above-average costs and healthcare utilization such as cardiac, hyperlipidemia, hypertension or diabetes patients. These findings appear in the current issue of the Journal of Medical Internet Research.
Experts unveil new CVD guidelines and position papers
Several new guidelines and position papers offering the most up to date information to ensure that clinicians practice evidence-based medicine were released at the Canadian Cardiovascular Congress 2009 this week.
Puberty a gateway to heart disease for Canada's teens
A seven-year ongoing study examining over 20,000 Canadian grade 9 students shows most already have at least one major risk factor for heart disease and stroke, Dr. Brian McCrindle told the Canadian Cardiovascular Congress 2009, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.
More Cardiovascular Risk Current Events and Cardiovascular Risk News Articles
 |
Clinical Management of Cardiovascular Risk Factors in Diabetes by Moser Marvin (Author), James R. Sowers (Author) Presents the rationale for why physicians should more aggressively treat hypertension and other CV risk factors in their diabetic patients. Specific therapeutic regimens for reducing CV events in diabetic patients are presented, including BP lowering, management of lipid abnormalities, antiplatelet therapy, and glucose control. |
 |
Reducing The Risk Of Cardiovascular Disease Dr. Andrew Weil (Primary Contributor) |
|
Managing Your Cardiovascular Risk Factors (Mayo Clinic Patient Education) Closed Captioned DVD. | |
 |
Best Cardiovascular Support - 60 Vcaps., (Doctor's Best) by HerbalLoveShop Science-Based Nutrition Featuring Flavoxine Helps Maintain Cholesterol Levels Already in the Normal Range Enhances Cardiovascular Function Dietary Supplement Flavoxine is a new, all natural patented proprietary combination of extracts from Citrus and Phellodendron amurense. Animal studies have shown that the ingredients in Flavoxine possess beneficial effects on heart function and support the maintenance of healthy levels of cholesterol. Supplementation with Flavoxine in a double-blind, placebo-controlled human clinical trial also resulted in significant benefits to cardiovascular health and cholesterol maintenance. Helps Maintain Cholesterol Levels Already in the Normal Range Promotes Healthy Heart Function |
 |
Cardiovascular Risk Management by Richard Hobbs (Author), Bruce Arroll (Author) Practical ABC style Enables doctors to prioritise treatment using risk-scoring systems and holistic recommendations for reducing cardiovascular risk Includes treatment plans for individuals with diabetes, who are at high risk of developing cardiovascular disease How to reduce cardiovascular risk in other specific patient groups Developed by expert groups in different regions of the world |
|
Cardiovascular Risk Abstracts by Euromed Communications | |
 |
Cardiovascular Disease in Racial and Ethnic Minorities (Contemporary Cardiology) by Keith C. Ferdinand (Editor), Annemarie Armani (Editor) Cardiovascular heart disease mortality in African Americans is the highest of all major racial/ethnic subpopulations in the United States. Examining race and ethnicity, Cardiovascular Disease in Racial and Ethnic Minorities will reveal that there are unacceptable healthcare disparities in risk factor prevalence, disease states, and cardiovascular outcomes in the United States. Written by a team of experts, Cardiovascular Disease in Racial and Ethnic Minorities examines to what degree biomedical and scientific literature can clarify the impact of genetic variation versus environment as related to cardiovascular disease. Chapters illustrate the magnitude of cardiovascular and metabolic disparities and the effect of environment on diseases. |
 |
Clinical Manual of Total Cardiovascular Risk by Neil R. Poulter (Author) The etiology of coronary heart disease and stroke has been known for decades to be multifactorial - an increasing risk of both CHD and stroke has been shown to have a graded continuous relationship with rising BP and total cholesterol across the whole BP and cholesterol ranges. The coexistance of other risk factors, such as smoking, obesity and age, has been shown to result in a dramatically increased risk. Alongside the numerous risk factors themselves, there is an ever increasing number of papers published aiming to stratify the risk factors. With an also increasing number of guidelines published, there is the need to simplify all of these data into a simple manual. "Clinician's Manual of Total Cardiovascular Risk" provides rapid answers to common clinical questions relating to... |
 |
Therapeutic Strategies in Cardiovascular Risk by Ian M. Graham (Editor), Ralph B. D'Agostino (Editor) The multi-factorial nature of cardiovascular disease has important implications for the planning of effective treatment strategies. Lifestyle factors such as diet, smoking history and exercise combine with endogenous predictors such as ethnicity and family history to give every individual a unique risk profile. To achieve a better outcome for the patient, we first need to understand how these factors work, singly and in combination, to cause or accelerate progression of disease. With this knowledge, we can then develop more effective strategies for management that incorporate changes in lifestyle as well as pharmacological combination therapy for hypertension, dyslipidaemia, etc. In this volume, the authors demonstrate how an ability to measure and quantify risk enables us to isolate key... |
 |
Atherosclerosis, Large Arteries and Cardiovascular Risk (Advances in Cardiology) by Michel E. Safar (Editor), Edward D. Frohlich (Editor) This book presents the current thinking of international experts regarding the underlying mechanisms of cardiovascular risk as well as the pathogenesis and pathophysiology of impaired large arterial stiffness and reduced large arterial distensibility. It also demonstrates the rationale for the present approach to the management and treatment of hypertensive diseases and atherosclerosis. The targeted readership includes basic scientists in vascular physiology as well as physicians and scientists in cardiovascular medicine, diabetes mellitus and renal diseases. |
| © 2009 BrightSurf.com |